Related Experiment Video
Updated: Aug 9, 2025
08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
2.5K
Avoidance Measures for Patients with Allergic Rhinitis: A Scoping Review
Miguel Tomé1, Olga Lourenço1,2
1FCS-UBI, Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.
Children (Basel, Switzerland)
|February 25, 2023
Summary
Environmental allergen control can reduce allergic rhinitis (AR) symptoms and improve quality of life. However, more research is needed to confirm the effectiveness of specific allergen avoidance strategies for AR management.
Area of Science:
- Allergy and Immunology
- Environmental Health
Background:
- Environmental allergen control is a key recommendation in allergic rhinitis (AR) management guidelines.
- Effective allergen avoidance strategies are crucial for improving patient outcomes.
Purpose of the Study:
- To identify and evaluate the effectiveness of environmental allergen control measures for managing allergic rhinitis.
- To synthesize evidence from randomized controlled trials and observational studies on allergen avoidance.
Main Methods:
- Systematic literature search conducted in PubMed, Cochrane Central Register of Controlled Trials, and Web of Science.
- Inclusion of studies on allergen eviction and exposure reduction for AR management.
- Scoping review of 18 selected studies meeting the inclusion criteria.
Main Results:
- Fifteen of the 18 included studies reported positive outcomes.
- Observed benefits included decreased AR symptom scores, improved quality of life, and reduced medication use.
- Limitations in study design and participant numbers were noted.
Conclusions:
- While many allergen avoidance measures show promise for AR management, definitive recommendations are hindered by study limitations.
- A comprehensive approach combining treatment, prevention, and environmental allergen eradication may be necessary for effective AR symptom reduction.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
375
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
375
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:16Drugs Used in Upper Respiratory Disorders: Overview
319
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
319
01:17Drugs Used in Lower Respiratory Disorders: Overview
528
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
528
01:29Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K